HK1045516A1 - Prodrugs of thrombin inhibitors - Google Patents

Prodrugs of thrombin inhibitors

Info

Publication number
HK1045516A1
HK1045516A1 HK02107043.0A HK02107043A HK1045516A1 HK 1045516 A1 HK1045516 A1 HK 1045516A1 HK 02107043 A HK02107043 A HK 02107043A HK 1045516 A1 HK1045516 A1 HK 1045516A1
Authority
HK
Hong Kong
Prior art keywords
prodrugs
thrombin inhibitors
thrombin
inhibitors
Prior art date
Application number
HK02107043.0A
Other languages
Chinese (zh)
Inventor
D‧鮑克
H‧馬克
W‧希茨
W‧霍恩伯格
G‧貝克菲施
J‧戴爾澤
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26004346&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1045516(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of HK1045516A1 publication Critical patent/HK1045516A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B43/00Formation or introduction of functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
HK02107043.0A 1999-04-09 2002-09-26 Prodrugs of thrombin inhibitors HK1045516A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19915930 1999-04-09
DE10006799 2000-02-15
PCT/EP2000/003008 WO2000061577A1 (en) 1999-04-09 2000-04-05 Prodrugs of thrombin inhibitors

Publications (1)

Publication Number Publication Date
HK1045516A1 true HK1045516A1 (en) 2002-11-29

Family

ID=26004346

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107043.0A HK1045516A1 (en) 1999-04-09 2002-09-26 Prodrugs of thrombin inhibitors

Country Status (16)

Country Link
EP (1) EP1169318A1 (en)
JP (1) JP2002541254A (en)
KR (1) KR20020004995A (en)
CN (1) CN1349526A (en)
AU (1) AU3659200A (en)
BG (1) BG105985A (en)
BR (1) BR0009653A (en)
CA (1) CA2368830A1 (en)
HK (1) HK1045516A1 (en)
HU (1) HUP0202431A3 (en)
IL (1) IL145670A0 (en)
NO (1) NO20014807L (en)
PL (1) PL352834A1 (en)
SK (1) SK14092001A3 (en)
TR (1) TR200102914T2 (en)
WO (1) WO2000061577A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10064797A1 (en) * 2000-12-22 2002-06-27 Knoll Ag Combination pack useful for the treatment of e.g. deep vein thrombosis and post-operative thrombosis, containing oral and parenteral formulations of thrombin inhibitor prodrugs
CA2489470A1 (en) * 2002-06-14 2003-12-24 Takeda Pharmaceutical Company Limited Prodrug and process for producing the same
TWI387053B (en) 2004-08-23 2013-02-21 Rokko Systems Pte Ltd Supply mechanism for the chuck of an integrated circuit dicing device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4421052A1 (en) * 1994-06-17 1995-12-21 Basf Ag New thrombin inhibitors, their production and use
CN1198839C (en) * 1995-02-17 2005-04-27 艾伯特有限及两合公司 Novel dipeptide amidines as thrombin inhibitors
DE19631084A1 (en) * 1996-08-01 1998-02-05 Basf Ag Use of (meth) acrylic acid copolymers to increase the permeability of the mucosa
DE19635674A1 (en) * 1996-09-03 1998-03-05 Basf Ag Process for the preparation of amidines

Also Published As

Publication number Publication date
SK14092001A3 (en) 2002-05-09
KR20020004995A (en) 2002-01-16
PL352834A1 (en) 2003-09-08
BG105985A (en) 2002-06-28
TR200102914T2 (en) 2002-01-21
WO2000061577A1 (en) 2000-10-19
NO20014807D0 (en) 2001-10-03
CN1349526A (en) 2002-05-15
NO20014807L (en) 2001-12-04
AU3659200A (en) 2000-11-14
HUP0202431A3 (en) 2003-03-28
CA2368830A1 (en) 2000-10-19
IL145670A0 (en) 2002-06-30
BR0009653A (en) 2002-01-08
EP1169318A1 (en) 2002-01-09
HUP0202431A2 (en) 2002-11-28
JP2002541254A (en) 2002-12-03

Similar Documents

Publication Publication Date Title
GB9912961D0 (en) Metalloprotease inhibitors
IL149118A0 (en) Inhibitors of neuraminidases
EP1124822A4 (en) Thrombin inhibitors
GB9900416D0 (en) Inhibitors
IL145772A0 (en) Prodrugs of thrombin inhibitors
IL145085A0 (en) Dihetero-substituted metalloprotease inhibitors
GB9930659D0 (en) Inhibitors of complement activation
EP1117660A4 (en) Thrombin inhibitors
IL136139A0 (en) Thrombin inhibitors
EP1153022A4 (en) Prothease inhibitors
GB0030284D0 (en) Enzyme inhibitors
EP1232155A4 (en) Protease inhibitors
EP1231921A4 (en) Protease inhibitors
EP1229915A4 (en) Protease inhibitors
EP1229914A4 (en) Protease inhibitors
EP1229912A4 (en) Protease inhibitors
EP1161237A4 (en) Protease inhibitors
EP1173429A4 (en) Protease inhibitors
EP1233771A4 (en) Protease inhibitors
EP1229911A4 (en) Protease inhibitors
EP1231923A4 (en) Protease inhibitors
IL145670A0 (en) Prodrugs of thrombin inhibitors
EP1189618A4 (en) Thrombin inhibitors
PL347152A1 (en) Benzamide derivatives as thrombin inhibitors
EP1231922A4 (en) Protease inhibitors